Columbus, OH, United States of America

Tao Zuo


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Inventor Tao Zuo

Introduction

Tao Zuo is a prominent inventor based in Columbus, OH (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on utilizing FOXP3 proteins to suppress tumor growth and improve cancer therapies.

Latest Patents

Tao Zuo holds a patent for "Materials and methods for FOXP3 tumor suppression." This patent outlines methods for treating cancer by administering a FOXP3 protein, a nucleic acid encoding a FOXP3 protein, or an inducing compound that promotes FOXP3 protein expression. The patent also describes techniques for altering the phenotype of cancer cells, inhibiting their growth, and inducing apoptosis. Additionally, diagnostic methods are provided to compare FOXP3 protein or gene expression in test samples against normal or prior samples. The patent further includes a method for screening test compounds for anti-cancer activity by measuring FOXP3 expression.

Career Highlights

Tao Zuo is affiliated with the University of Michigan, where he conducts his research and develops innovative cancer treatment methods. His work has garnered attention for its potential to improve therapeutic outcomes for cancer patients.

Collaborations

Tao Zuo collaborates with notable colleagues, including Yang Liu and Pan Zheng, who contribute to his research efforts and advancements in cancer treatment.

Conclusion

Tao Zuo's innovative work in cancer treatment through the development of FOXP3-related methods showcases his commitment to advancing medical science. His contributions have the potential to significantly impact cancer therapies and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…